miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1

被引:9
|
作者
Wang, Yanzhe [1 ]
Liu, Yuyuan [1 ]
Zhang, Ling [1 ]
Bai, Linnan [1 ]
Chen, Sijia [1 ]
Wu, Hao [1 ]
Sun, Linlin [1 ]
Wang, Xiaoxia [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Nephrol, Sch Med, Shanghai, Peoples R China
基金
中国国家自然科学基金; 上海市自然科学基金;
关键词
miR-30b-5p; SNAI1; Epithelial-to-mesenchymal transition (EMT); Diabetic kidney disease (DN); ACTIVATION; EXPRESSION; FIBROSIS; BETA;
D O I
10.1016/j.bbrc.2020.10.096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Object: Renal tubulointerstitial fibrosis plays a significant role in the development of diabetic nephropathy (DN). SNAl1 is a main activator of epithelial-to-mesenchymal transition (EMT) in the process of fibrosis. This study aimed to investigate the effect of miR-30b-5p targeting SNAIL on the EMT in DN. Methods: Bioinformatics and miRNAs microarray analyses were used to predict the candidate miRNA targeting SNAIL, that is miR-30b-5p. The db/db mice was as DN animal model and renal tissues of mice were stained with PAS. The miR-30b-5p expression in mouse and human renal tissue were examined by quantitative RT-PCR (qRT-PCR) and fluorescence in situ hybridization (FISH), while SNAIL expression was determined by qRT-PCR and immunohistochemistry. Luciferase reporter gene assay was used to confirm miR-30b-5p directly target 3'-UTR of the SNAIL mRNA. In vitro, HK-2 cells were treated with high glucose to establish hyperglycemia cell model and transfected with miR-30b-5p mimics to overexpress miR-30b-5p. Expression of miR-30b-5p, SNAI1 and EMT related indicators (E-cadherin, a-SMA and Vimentin) in HK-2 cells under different treatments were determined by qRT-PCR and/or western-blot. In addition, immunofluorescence was performed to evaluate a-SMA expression in HK-2 cells under different treatments. Results: Bioinformatics analyses revealed miR-30b-5p had complementary sequences with SNAIL mRNA and the seed region of miR-30b-5p was conserved in human and a variety of animals, including mice. Microarray analysis showed miR-30b expression decreased in DN mice, which was further verified in db/ db mice by qRT-PCR and in human DN by FISH. Contrary to miR-30b-5p, SNAI1 expression level was upregulated in db/db mice. Correlation analysis suggested SNAI1 mRNA level was negatively with miR30b-5p level in renal tissue of db/db mice. Luciferase reporter gene assay confirmed miR-30b-5p directly targeted SNAI1 mRNA. In high glucose induced HK-2 cells, expression levels of miR-30b-5p and E-cadherin were decreased, while SNAI1, a-SMA and Vimentin were increased. Overexpression miR-30b-5p in high glucose induced HK-2 cells could reverse that phenomenon to some extent. Conclusion: These findings suggest that miR-30b-5p play a protective role by targeting SNAI1 in renal EMT in DN. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [21] Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway
    Alaaeldin, Rania
    Mohyeldin, Reham H.
    Bekhit, Amany Abdlrehim
    Gomaa, Wafaey
    Zhao, Qing-Li
    Fathy, Moustafa
    MOLECULES, 2023, 28 (12):
  • [22] MicroRNA-30a-3p regulates epithelial-mesenchymal transition to affect embryo implantation by targeting Snai2
    Li, Lin
    Gou, Jinhai
    Yi, Tao
    Li, Zhengyu
    BIOLOGY OF REPRODUCTION, 2019, 100 (05) : 1171 - 1179
  • [23] miR-302b suppresses the high-sucrose induced epithelial-mesenchymal transition in diabetic nephropathy
    Zhang, Chengjie
    Yang, Pingling
    Li, Aimei
    Li, Qing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9283 - 9289
  • [24] FOXD1 promotes proliferation, migration, and epithelial-mesenchymal transformation in esophageal squamous cell carcinoma by targeting SNAI1
    Wu, Zheng
    Li, Wen
    Zhu, Hui
    Guo, Shenghu
    Zhang, Yuehua
    Zhang, Lei
    Guo, Xiaojin
    Cao, Jing
    Wang, Zhiyu
    PROCESS BIOCHEMISTRY, 2024, 138 : 47 - 56
  • [25] EXOSOMAL MIR-92A-1-5P DERIVED FROM PROXIMAL TUBULAR EPITHELIAL CELLS INDUCES EPITHELIAL-MESENCHYMAL TRANSITION IN MESANGIAL CELLS IN DIABETIC NEPHROPATHY
    Tsai, Yi-Chun
    Kuo, Mei-Chuan
    Hsu, Ya-Ling
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1293 - 1293
  • [26] MiR-150-5p Alleviates Renal Tubule Epithelial Cell Fibrosis via the Inhibition of Epithelial-Mesenchymal Transition by Targeting ZEB1
    Zhang, Zhizhong
    Zhang, Xinyu
    Gao, Xiangming
    Fang, Bing
    Tian, Shuyu
    Kang, Ping
    Zhao, Yi
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (09) : 827 - 835
  • [27] miR-525-5p Modulates Proliferation and Epithelial-Mesenchymal Transition of Glioma by Targeting Stat-1
    Xie, Peng
    Han, Qiu
    Liu, Dachao
    Yao, Dan
    Lu, Xiaoqing
    Wang, Ziyu
    Zuo, Xiaohua
    ONCOTARGETS AND THERAPY, 2020, 13 : 9957 - 9966
  • [28] MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer
    Kumarswamy, Regalla
    Mudduluru, Giridhar
    Ceppi, Paolo
    Muppala, Santoshi
    Kozlowski, Miroslaw
    Niklinski, Jacek
    Papotti, Mauro
    Allgayer, Heike
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (09) : 2044 - 2053
  • [29] Original MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway
    Wei, Meng
    Yang, Ran
    Ye, Mujie
    Zhan, Yong
    Liu, Baihui
    Meng, Lingdu
    Xie, Lulu
    Du, Min
    Wang, Junfeng
    Gao, Runnan
    Chen, Deqian
    Dong, Rui
    Dong, Kuiran
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (05): : 1960 - +
  • [30] miR-194 suppresses epithelial-mesenchymal transition of retinal pigment epithelial cells by directly targeting ZEB1
    Cui, Lian
    Lyu, Yali
    Jin, Xiaoliang
    Wang, Yueye
    Li, Xiang
    Wang, Juan
    Zhang, Jieping
    Deng, Zhongzhu
    Yang, Nan
    Zheng, Zixuan
    Guo, Yizheng
    Wang, Chao
    Mao, Rui
    Xu, Jingying
    Gao, Furong
    Jin, Caixia
    Zhang, Jingfa
    Tian, Haibin
    Xu, Guo-Tong
    Lu, Lixia
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (23)